📋 FDA Reference

Advance 14rx Rapid Exchange PTA Balloon Catheter

Cook Incorporated

Contact Cook Incorporated ↗ Compare similar devices

Summary: The Advance 14RX Rapid Exchange PTA Balloon Catheter by Cook is used for percutaneous transluminal angioplasty (PTA) procedures, primarily in venous stent placements. It is typically utilized by interventional radiologists and vascular surgeons.

FDA Clearance Information

Pathway ? 510(k)
Number ? K090822 ↗
Decision Date ? April 27, 2009
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

The Advance 14RX Rapid Exchange PTA Balloon Catheter was cleared through the FDA 510(k) pathway on April 27, 2009. Manufactured by Cook, it is classified as a Class 2 device under product code DQY.

What It Is

The Advance 14RX Rapid Exchange PTA Balloon Catheter is a medical device designed for percutaneous transluminal angioplasty, a procedure to open narrowed or blocked blood vessels. The catheter features a balloon that can be inflated to dilate the vessel, improving blood flow. Its rapid exchange design allows for easier and quicker catheter exchanges during procedures, enhancing efficiency and reducing procedural time.

FDA-Cleared Indications

  • Dilation of stenotic or obstructed peripheral blood vessels during percutaneous transluminal angioplasty.
  • Use in the peripheral vasculature when balloon dilation is clinically indicated.

Clinical Applications

  • Balloon angioplasty of narrowed peripheral blood vessels.
  • Dilation of venous stenoses or obstructions during endovascular treatment.
  • Post-deployment expansion or optimization of a peripheral venous stent when balloon dilation is indicated.
  • Treatment of impaired blood flow caused by venous narrowing or obstruction.

Reported off-label uses

  • Balloon dilation of selected dialysis access stenoses when the device size and labeling are appropriate.
  • Treatment of selected arterial lesions in clinical practice, although the specific vessel and indication should be confirmed against the current device labeling.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The catheter is designed for rapid exchange over a standard 0.014-inch guidewire; the required guidewire length and compatibility should be confirmed before use.
  • Available balloon diameters and lengths vary by model. Select a size appropriate for the target vessel and follow the labeled rated burst pressure.
  • The procedure is performed under fluoroscopic imaging, usually through vascular access such as the femoral or jugular vein, depending on the target anatomy.
  • Do not overinflate the balloon. Potential complications include vessel dissection, perforation, thrombosis, embolization, bleeding, infection and recurrence of narrowing.
  • MRI safety depends on the specific catheter model and whether it remains in the patient. Review the current manufacturer instructions for use; it is generally removed after angioplasty.

Procedures that use this device

Frequently Asked Questions

What is the Advance 14RX Rapid Exchange PTA Balloon Catheter used for?

It is used for percutaneous transluminal angioplasty to dilate narrowed or obstructed veins, often in conjunction with venous stent placements.

What specialties typically use this device?

Interventional radiologists and vascular surgeons commonly use this device in hospital settings.

What are the FDA-cleared indications?

The device is indicated for use in procedures to dilate narrowed or obstructed venous pathways, improving blood flow in conditions like venous insufficiency.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you